Another example of an anti-cancer CAR γδ T cell is the anti-mesothelin CAR Vδ2 T cell enhanced with increased CD16 expression to augment ADCC, with or without additional increased IL-15 expression, for targeting ovarian cancers [210]. This evidence concerns the gene IL15 and ovarian cancer.